tiprankstipranks
Astrana Health Inc. (ASTH)
NASDAQ:ASTH
US Market
ASTH
Astrana Health
RESEARCH TOOLSreports
Want to see ASTH full AI Analyst Report?

Astrana Health (ASTH) Stock Forecast & Price Target

270 Followers
See the Price Targets and Ratings of:

ASTH Analyst Ratings

Strong Buy
9Ratings
Strong Buy
7 Buy
2 Hold
0 Sell
Based on 9 analysts giving stock ratings to
Astrana
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ASTH Stock 12 Month Forecast

Average Price Target

$41.57
▲(123.62% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Astrana Health in the last 3 months. The average price target is $41.57 with a high forecast of $47.00 and a low forecast of $36.00. The average price target represents a 123.62% change from the last price of $18.59.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"$20","27":"$27","34":"$34","41":"$41","48":"$48"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$47.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":41.57142857142857,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$41.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$36.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,27,34,41,48],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.89,35.82153846153846,36.753076923076925,37.684615384615384,38.61615384615385,39.54769230769231,40.47923076923077,41.41076923076923,42.34230769230769,43.27384615384615,44.20538461538462,45.136923076923075,46.06846153846154,{"y":47,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.89,35.40395604395604,35.917912087912086,36.43186813186813,36.94582417582418,37.45978021978022,37.973736263736264,38.487692307692306,39.00164835164835,39.51560439560439,40.02956043956044,40.543516483516484,41.05747252747253,{"y":41.57142857142857,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.89,34.97538461538461,35.06076923076923,35.146153846153844,35.23153846153846,35.316923076923075,35.402307692307694,35.487692307692306,35.573076923076925,35.65846153846154,35.74384615384616,35.82923076923077,35.91461538461539,{"y":36,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":31.44,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.06,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.57,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.88,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.16,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.21,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.18,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.81,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.32,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.32,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.51,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.89,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$47.00Average Price Target$41.57Lowest Price Target$36.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on ASTH
Jailendra Singh
Truist Financial
Truist Financial
$38→$47
Buy
152.82%
Upside
Assigned
05/14/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bank of America Securities Analyst forecast on ASTH
Michael Craig Jones
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH), Bristol-Myers Squibb (NYSE: BMY) and Progyny (NASDAQ: PGNY)
TD Cowen Analyst forecast on ASTH
Ryan Langston
TD Cowen
TD Cowen
$35→$45
Buy
142.07%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH) and Maravai Lifesciences Holdings (NASDAQ: MRVI)
Barclays Analyst forecast on ASTH
Andrew Mok CFA
Barclays
Barclays
$26→$37
Hold
99.03%
Upside
Assigned
05/11/26
Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Astrana Health (NASDAQ: ASTH) and Pacific Biosciences (NASDAQ: PACB)
Needham Analyst forecast on ASTH
Matthew Shea
Needham
Needham
$41
Buy
120.55%
Upside
Assigned
05/08/26
Needham Sticks to Their Buy Rating for Astrana Health (ASTH)
Robert W. Baird Analyst forecast on ASTH
Michael Ha
Robert W. Baird
Robert W. Baird
$40→$45
Buy
142.07%
Upside
Reiterated
05/08/26
Astrana Health price target raised to $45 from $40 at BairdAstrana Health price target raised to $45 from $40 at Baird
William Blair Analyst forecast on ASTH
Ryan Daniels
William Blair
William Blair
$36
Buy
93.65%
Upside
Reiterated
05/07/26
Analysts Are Bullish on These Healthcare Stocks: Definitive Healthcare Corp (DH), Astrana Health (ASTH)
KeyBanc Analyst forecast on ASTH
Matthew Gillmor CFA
KeyBanc
KeyBanc
―
Hold
―
Reiterated
03/03/26
Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH), Becton Dickinson (NYSE: BDX) and United Therapeutics (NASDAQ: UTHR)
BTIG Analyst forecast on ASTH
David Larsen
BTIG
BTIG
$40
Buy
115.17%
Upside
Reiterated
03/02/26
Analysts Conflicted on These Healthcare Names: Apogee Therapeutics (NASDAQ: APGE), Astrana Health (NASDAQ: ASTH) and Senseonics Holdings (NASDAQ: SENS)
Jefferies Analyst forecast on ASTH
Jack Slevin
Jefferies
Jefferies
$44→$37
Buy
99.03%
Upside
Reiterated
11/25/25
Astrana Health price target lowered to $37 from $44 at JefferiesAstrana Health price target lowered to $37 from $44 at Jefferies
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on ASTH
Jailendra Singh
Truist Financial
Truist Financial
$38→$47
Buy
152.82%
Upside
Assigned
05/14/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bank of America Securities Analyst forecast on ASTH
Michael Craig Jones
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH), Bristol-Myers Squibb (NYSE: BMY) and Progyny (NASDAQ: PGNY)
TD Cowen Analyst forecast on ASTH
Ryan Langston
TD Cowen
TD Cowen
$35→$45
Buy
142.07%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH) and Maravai Lifesciences Holdings (NASDAQ: MRVI)
Barclays Analyst forecast on ASTH
Andrew Mok CFA
Barclays
Barclays
$26→$37
Hold
99.03%
Upside
Assigned
05/11/26
Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Astrana Health (NASDAQ: ASTH) and Pacific Biosciences (NASDAQ: PACB)
Needham Analyst forecast on ASTH
Matthew Shea
Needham
Needham
$41
Buy
120.55%
Upside
Assigned
05/08/26
Needham Sticks to Their Buy Rating for Astrana Health (ASTH)
Robert W. Baird Analyst forecast on ASTH
Michael Ha
Robert W. Baird
Robert W. Baird
$40→$45
Buy
142.07%
Upside
Reiterated
05/08/26
Astrana Health price target raised to $45 from $40 at BairdAstrana Health price target raised to $45 from $40 at Baird
William Blair Analyst forecast on ASTH
Ryan Daniels
William Blair
William Blair
$36
Buy
93.65%
Upside
Reiterated
05/07/26
Analysts Are Bullish on These Healthcare Stocks: Definitive Healthcare Corp (DH), Astrana Health (ASTH)
KeyBanc Analyst forecast on ASTH
Matthew Gillmor CFA
KeyBanc
KeyBanc
―
Hold
―
Reiterated
03/03/26
Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH), Becton Dickinson (NYSE: BDX) and United Therapeutics (NASDAQ: UTHR)
BTIG Analyst forecast on ASTH
David Larsen
BTIG
BTIG
$40
Buy
115.17%
Upside
Reiterated
03/02/26
Analysts Conflicted on These Healthcare Names: Apogee Therapeutics (NASDAQ: APGE), Astrana Health (NASDAQ: ASTH) and Senseonics Holdings (NASDAQ: SENS)
Jefferies Analyst forecast on ASTH
Jack Slevin
Jefferies
Jefferies
$44→$37
Buy
99.03%
Upside
Reiterated
11/25/25
Astrana Health price target lowered to $37 from $44 at JefferiesAstrana Health price target lowered to $37 from $44 at Jefferies
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Astrana Health

3 Months
xxx
Success Rate
8/12 ratings generated profit
67%
Average Return
+8.08%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +8.08% per trade.
1 Year
Ryan DanielsWilliam Blair
Success Rate
7/9 ratings generated profit
78%
Average Return
+32.31%
Copying Ryan Daniels's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +32.31% per trade.
2 Years
xxx
Success Rate
9/9 ratings generated profit
100%
Average Return
+46.62%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +46.62% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ASTH Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
4
2
4
3
2
Buy
7
4
6
7
15
Hold
2
0
2
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
6
12
12
20
In the current month, ASTH has received 17 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ASTH average Analyst price target in the past 3 months is 41.57.
Each month's total comprises the sum of three months' worth of ratings.

ASTH Financial Forecast

ASTH Earnings Forecast

Next quarter’s earnings estimate for ASTH is $0.33 with a range of $0.26 to $0.39. The previous quarter’s EPS was $0.29. ASTH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ASTH has Performed in-line its overall industry.
Next quarter’s earnings estimate for ASTH is $0.33 with a range of $0.26 to $0.39. The previous quarter’s EPS was $0.29. ASTH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ASTH has Performed in-line its overall industry.

ASTH Sales Forecast

Next quarter’s sales forecast for ASTH is $985.02M with a range of $965.90M to $1.00B. The previous quarter’s sales results were $965.10M. ASTH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ASTH has Performed in-line its overall industry.
Next quarter’s sales forecast for ASTH is $985.02M with a range of $965.90M to $1.00B. The previous quarter’s sales results were $965.10M. ASTH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ASTH has Performed in-line its overall industry.

ASTH Stock Forecast FAQ

What is ASTH’s average 12-month price target, according to analysts?
Based on analyst ratings, Astrana Health Inc.’s 12-month average price target is 41.57.
    What is ASTH’s upside potential, based on the analysts’ average price target?
    Astrana Health Inc. has 123.62% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ASTH a Buy, Sell or Hold?
          Astrana Health Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Astrana Health Inc.’s price target?
            The average price target for Astrana Health Inc. is 41.57. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $47.00 ,the lowest forecast is $36.00. The average price target represents 123.62% Increase from the current price of $18.59.
              What do analysts say about Astrana Health Inc.?
              Astrana Health Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of ASTH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.